TNXA and Ehlers-Danlos syndrome, hypermobility type: CYP21A1P-TNXA/TNXB chimeras are responsible for the majority of known hEDS cases amongst the CAH population, known as “CAH-X”, named for CAH with tenascin-X defects [4,5,9].